Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)

Recruiting Observational Study
Tuberous Sclerosis Complex Lymphangioleiomyomatosis
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Female
Study type
Observational
Participants needed
300 (estimated)
Sponsor
David M. Ritter · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study is an observational registry designed to gather information about Tuberous Sclerosis Complex (TSC) and Lymphangioleiomyomatosis (LAM) in pregnant women and their child.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * A pregnant woman with a clinical or genetic diagnosis of TSC as determined by the 2021 Consensus Guidelines (1) * A pregnant woman with a diagnosis of LAM * A pregnant woman with a variant of uncertain significance in TSC 1 or TSC 2 * A pregnant woman who is pregnant and the f…
Contacts

Molly S Griffith, BA

513-636-9669

molly.griffith@cchmc.org

CONTACT

Adrienne Victory

513-636-8016

adrienne.victory@cchmc.org

CONTACT